Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market size is forecast to reach USD 3,129 million by 2025, estimated to grow at a CAGR of 46.7% during 2018-2025.

Connected Drug Delivery Devices Market Overview

Connected drug delivery devices are widely used among healthcare professionals as well as patients. Connected drug delivery devices are designed in a way to accomplish a multifunctional task as it helps to record and remind dossing pattern, addressing the issues related to the medication management, etc. Connected drug delivery devices are basically user-friendly, patient-centric, quick and efficient, easily accessible. The deployment of connected drug delivery devices is gaining traction across the globe.

To have an edge over the competition by knowing the market dynamics and current trends of “Connected drug delivery devices market”, request for Sample Report here

Major Connected Drug Delivery Devices Market Drivers

Factors such as the growing incidence of chronic disease, increasing geriatric population and rising preference for connected injectable drug delivery are driving the growth of global connected drug delivery device market during the forecast period. In addition, cloud-based computing models, the proliferation of mobile health application, introduction of the monitoring device and advancement in healthcare IT are leading the healthcare industry towards the new era. Moreover, increase use of self-administration of drugs through connected drug delivery device and penetration of artificial intelligence technology and big data analytics, especially for real-time decision making to manage medication is expected to fuel the growth of the market. One of the key challenges for widespread adoption in connected drug delivery applications remains the integration of electronic communications systems into the devices. However, cost containment, inadequate reimbursement policies in emerging countries and lack of awareness among patient regarding the latest technology are the major factors that are restraining the growth of global connected drug delivery devices market over the coming few years.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Top Market Players

Various notable players operating in the market, include Phillips-Medisize, West Pharmaceutical Service, Biocorp Production SA, Aterica, Unilife Corporation, Panasonic, Propeller Health, Qualcomm Technologies, Bayer AG, 3M Company among others. Most of the pharmaceutical company are focusing on strategic collaboration with tech firms to design and developed innovative product. For instance, Propeller Health entered into a strategic partnership with Express Scripts to provide digital solutions to Express Script members.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Segments covered in the Report:

The Connected drug delivery devices market has been segmented on the basis of product type, technology, end-users, and key geographies. Based on product type, the market comprises of inhalation devices, solid dosage forms devices and injectable device. The research report “global connected drug delivery devices market” provides in-depth analysis of global connected drug delivery devices market based on product type, technology, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global connected drug delivery devices market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For detailed scope of the “Connected drug delivery devices market” report request a Sample Copy of the report

Market Segmentation

By Product Type

• Inhalation Devices
• Solid Dosage Forms Devices
• Injectable Devices
o Handheld Injectable Devices
o Wearable Injectable Devices

By Technology

• Bluetooth
• Near Field Communication
• Others

By End-Users

• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings

By Geography

• North America
As a part of customization
o By Product Type
o By Technology
o By End users
o US
o Canada
o Mexico

• Europe
As a part of customization
o By Product Type
o By Technology
o By End users
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Product Type
o By Technology
o By End users
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of customization
o By Product Type
o By Technology
o By End users
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• Phillips-Medisize;
• West Pharmaceutical Service
• Biocorp Production SA
• Aterica
• Unilife Corporation
• Panasonic
• Propeller Health
• Qualcomm Technologies
• Bayer AG
• 3M Company

*Other prominent players in the market which can be profiled as a part of customization:
CeQurSA
CareTRx
CoheroHealth
Teva Pharmaceutical Industries Ltd